Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin1, 2, 3, 4

Journal of the National Cancer Institute

Volumn 67, Issue 4, 1981, Pages 947-956

  Barnes, Zoa ^a   Fidler, Isaiah J ^a   Gruys, Eilene ^a   Cifone, Maria A ^a   Bucana, Corazon ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Mammalian Genetics Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CANCER CELL; CANCER GRAFT; CLONE; CYTOLOGY; ELECTRON MICROSCOPY; MELANOMA; METASTASIS; MOUSE; PHENOTYPE;

ANIMALS; CELL DIVISION; CELL LINE; CLONE CELLS; MELANOMA; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL;

EID: 0019787737     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/67.4.947     Document Type: Article

References (40)

1. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastasis. Adv Cancer Res 1978; 28:149–250.
2. Fidler IJ. Tumor heterogeneity and the biology of cancer in vasion and metastasis. Cancer Res 1978; 38:2651–2660.
3. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197:893–895.
4. Fidler IJ, Kripke ML. Tumor cell antigenicity, host immunity and cancermetastasis. Cancer Immunol Immunother 1980; 7:201–205.
5. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Fogler R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978; 38:3174–3181.
6. Fogel M, Gorelik E, Segal S, Feldman M. Differences in cellsurface antigens of tumor metastases and those of the local tumor. JNCI 1979; 62:585–588.
7. Fugi H, Mihich E. Selection for high immunogenicity in drug resistant sublines of murine lymphomas demonstrated by plaque assay. Cancer Res 1975; 35:945–952.
8. Gray JM, Pierce GB. Relationship between growth rate and differentiation of melanoma in vivo. J Natl Cancer Inst 1964; 32:1201–1211.
9. HAkansson L, TropÉ C. On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. Acta Pathol Microbiol Scand [A] 1974; 82:35–40.
10. Hart IR. Selection and characterization of an invasive variant of the B16 melanoma. Am J Pathol 1980; 97:587–600.
11. Ljotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM. Metastatic potential correlates with enzymatic degradation of basement membrane collage. Nature 1980; 284:67–68.
12. Heppner GH, Dexter DL, Denucci T, Miller FR, Calabresi P. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res 1978; 38:3758–3763.
13. Kerbel RS. Implications of immunological heterogeneity of tumours. Nature 1979; 280:358–360.
14. Kerbel RS, Twiddy RR, Robertson DM. Induction of a tumor with greatly increased metastatic growth potential. Int J Cancer 1978; 22:583–594.
15. Killion JJ, Kollmorgen GM. Isolation of immunogenic tumour cells by cell-affinity chromatography. Nature 1976; 259:674–675.
16. Kripke ML, Gruys E, Fidler IJ. Metastatic heterogeneity of cells from an ultraviolet light induced murine fibrosarcoma of recent origin. Cancer Res 1978; 38:2962–2967.
17. Nicolson GL, Brunson KW, Fidler IJ. Specificity of arrest, survival and growth of selected metastatic variant cell lines. Cancer Res 1978; 38:4105–4111.
18. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283:139–146.
19. Prehn RT. Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas. J Natl Cancer Inst 1970; 45:1039–1045.
20. Sluyser M, Van Nie R. Estrogen receptor content and hormone-responsive growth of mouse mammary tumors. Cancer Res 1974; 34:3252–3257.
21. Suzuki N, Withers R, Koehler MW. Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. Cancer Res 1978; 34:3349–3351.
22. Talmadge JE, Starkey JR, Davis WC, Cohen AL. Introduction of metastatic heterogeneity by short-term in vivo passage of a cloned transformed cell line. J Supramol Struct 1979; 12:227–243.
23. Trope C. Different sensitivity to cytostatic drugs of primarytumor and metastasis of the Lewis carcinoma. Neoplasm 1975; 22:171–180.
24. Brunson KW, Nicolson GL. Selection and biologic properties of malignant variants of a murine lymphosarcoma. JNCI 1978; 61:1499–1503.
25. Heppner GH. The challenge of tumor heterogeneity. In: Bul-brook RD, Taylor DJ, eds., Commentaries on research in breast disease. New York: Liss, 1979:177–191.
26. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194:23–28.
27. Kripke ML. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. JNCI 1979; 63: 541–548.
28. Fidler IJ, Kripke ML. Metastatic heterogeneity of cells from the K-1735 melanoma. In: Grundmann E, ed. Metastatic tumor growth. Stuttgart: Fischer, 1980:71–81.
29. Hanna N, Fidler IJ. Role of natural killer cells in the destruction of circulating tumor emboli. JNCI 1980; 65:801–809.
30. Hanna N. Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer 1980; 26:675–680.
31. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
32. Qfone MA, Fidler IJ. Correlation of patterns of anchorage-dependent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 1980; 77:1039–1043.
33. Qfone MA, Kripke ML, Fidler IJ. Growth rate and chromo some number of tumor cell lines with different metastatic potential. J Supramol Struct 1979; 11:467–476.
34. Luria SE, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943; 28:491–511.
35. Yuhas JM, Li AP. Growth fraction as the major determinant of multicellular tumor spheroid growth rates. Cancer Res 1978; 38:1528–1532.
36. Zeidman I. Metastasis: A review of recent advances. Cancer Res 1957; 17:157–162.
37. Sato H, Suzuki M. Deformability and viability of tumor cells by transcapillary passage, with references to organ affinity of metastasis in cancer. In: Weiss L, ed. Fundamental aspects of metastasis. New York: Elsevier/North-Holland, 1976:311–317.
38. Hart IR, Raz A, Fidler IJ. Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells. JNCI 1980; 64:891–900.
39. Reddy AL, Fialkow PJ. Multicellular origin of fibrosarcomas in mice induced by the chemical carcinogen 3-methylcholan-threne. J Exp Med 1979; 150:878–886.
40. Fialkow PJ. Clonal origin of human tumors. Biochim Biophys Acta 1976; 458:283–310.